understood Boo but the one aspect i've learned to rarely

New Post Public Reply Private Reply Replies (1) Message Board
4kids BooDog #54559
383
understood Boo

but the one aspect i've learned to rarely speculate about is mgmt's timing
(imo everything always takes longer and is more layered than *imo* most investors can appreciate)

by not speculating about timing .. i don't set myself up for potential frustration
which is another rule of mine .. take emotions out of equation specific to equities
regardless of where *traded*

rather i watch to see what has been done and is being done .. and not just by mgmt

this way if mgmt delivers today .. tomorrow .. next week .. next month or next year provided my caveats are met .. i remain invested and continue (usually via bid support) to pick off shares .. again having learned NRs' patterns .. i never go all in into an OTC target .. rather watch and pick selectively .. the more NR reveals that fits *imo* their well known efforts .. the more i tend to pick off as able to .. as i've noted it was mgmt's aggressive response of 2015 to *well established* NR patterns always in play re: the OTC .. when *hand off* doesn't go as NR *anticipated* .. that (besides company's imo diverse platform) kept me as an investor

imo usually by the time a targeted mgmt has *awareness* of NRs' *efforts*.. it's almost always too late .. blown out I/Os become the norm

that is why for all the whining that gets done by rote by NRs' trading crews et al
i don't focus on the targets' PPS .. rather on what mgmt executes

and perhaps again just me.. but i've never expected *seamless* out of an OTC target under attack for years .. as Innovation Pharma has been ..

as noted previously the *gamble* the significantly upside down NR (non retail) undertook *again* specifically last September 12th against Innovation Pharma via IPIX .. *failed*

how spectacularly that failure is .. imo will be known by all with interest with mgmt delivering a sequence of material events that *cant* be misunderstood by anyone

4kids

second is *imo* most with functioning gray matter could understand today's news

I liked the whole post but wanted to highlight the above part.

First of all, I know that we know there is a process of moving a drug through to start any trial. I also know that they know when that process is nearing a critical catalyst.

That catalyst is announcing the protocol and funding to make it happen.

I think we're pretty split on when that'll be announced. Before or after the mid April meeting. I think it would be prudent to get it all on the street before the meeting but really, it doesn't matter as long as it gets done. And soon. From the news they clearly already have a protocol.

In December, Innovation Pharmaceuticals completed an End-of-Phase 2 Meeting with the U.S. Food and Drug Administration (FDA), during which an acceptable Phase 3 development pathway was agreed upon to advance Brilacidin.

EMA advice is integral to this plan by helping to ensure that the program meets European standards.

For the Phase 3 program, the Company anticipates international clinical trial enrollment, with participating sites located in the U.S. and in Europe.

Now we just need Leo & Dr. B to show us the money!

Any day now. Within about 12-18 days.


Mr. Obvious


Quote:
but 4 things stand out today .. (5th will be what DRS shows me)

first is news came out pre mkt .. which allowed CSTI to then UC the ask and block via their UC ask b4 mkt opened (i'll break out those blocks on today's tape of trades)
second is *imo* most with functioning gray matter could understand today's news
remember my adage .. *if able to* a significantly upside down NR has to make good news look bad (close down on volume) .. and bad news look fatal (significant close down on significant volume) .. IPIX closing green on lower volume did not work in NRs' favor today
third .. NR could not do volume maintenance on IPIX (NR has issues) .. tho' they came close to 10 day vol algos .. close doesn't cut it
fourth .. very rough count on hidden trades today (25000 - 30000) .. % approx 10% .. below what has been done *recently*

IPIX Volume 286,544
Volume (10 day Average) 291,618
Volume (90 day Average) 480,693

be interesting to see what tomorrow brings once there is a little digestion of today's news ..

4kids



They know who they are. And when the money hits the street, they're toast.




Innovation Pharmaceuticals Inc (IPIX) Stock Research Links

IPIX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Viam and NYC FIRST: A Robotics Education Revolution

Updated Category News Views 60

Redefining Robotics Education in New York City Schools What happens when you blend tech innovation with education? Well, in the heart of New York City, Viam and NYC FIRST are shaking up the robotics scene. It's like introducing kids to an entirely new world where they can roll up their sleeves and tinker with tomorrow's technology today. It's about making robotics...

Continue Reading
Noah's Q3 2026 Earnings: What Investors Should Watch

Updated Category News Views 29

Anticipation Builds for Noah's Earnings Report A penny for your thoughts? More like a truckload for some insights on Noah Holdings (NYSE: NOAH). They’re taking the stage to drop their Q3 2026 earnings on November 24, after the markets put their feet up. If you're tracking global wealth managers, especially those dancing on the NYSE and the Hong Kong Stock Exchange...

Continue Reading
Yancheng's Harmony: Wetlands Embrace Future Growth

Updated Category News Views 100

Yancheng Wetlands: A Masterclass in Nature and Progress Sometimes, you come across a story that blends an old-school respect for nature with cutting-edge progress—Yancheng's wetlands are the real deal. Ten thousand years ago, this land was swallowed by the sea. Fast forward to the present, and you'll find 520,000 hectares of wetlands teeming with life, hosting over...

Continue Reading
Huawei Shakes Up Home Energy With LUTERRA S2

Updated Category News Views 115

Welcome to the Future of Home Energy If you thought home energy systems couldn't get any slicker, Huawei's got news for you. They just dropped the LUTERRA S2, a swanky, all-in-one residential energy system that's about to put your old setup to shame. This ain’t your granddad's inverter. We're talking hybrid functionality with storage and AI-driven energy management...

Continue Reading
Envision Energizes Türkiye's Green Power Future Ambitions

Updated Category News Views 93

Türkiye's Energy Vision Gains Momentum When you talk about energy transition, you can't ignore Türkiye's ambitious plans. Türkiye's Energy Minister, H.E. Alparslan Bayraktar, is rolling up his sleeves for a bold push into renewables. On the sidelines of COP31, he sat down with Envision Energy's main dealmaker, Kane Xu, to chew over how they can power up Türkiye’s...

Continue Reading
Lument Finance's Q3 2026 Numbers: A Critical Analysis

Updated Category News Views 45

LFT Posts Significant Loss in Q3 2026 It's third quarter earnings season, and Lument Finance Trust, Inc. (NYSE: LFT) is out here making headlines for all the wrong reasons. We're talking about a whopper of a GAAP net loss totalling $13.5 million—yep, you read that right—equating to a bruising $2.57 per share. Frankly, in this business, such numbers are akin to a...

Continue Reading
Candy Crush Celebrates XBOX: A Playful Nostalgic Twist

Updated Category News Views 16

When Candy Brands Meet Gaming Legends Who would have thought a saccharine mobile game could bring heavy-hitting franchises like Halo and DOOM to the soft world of candies? But that's exactly what Candy Crush Saga is doing to mark XBOX's 25th anniversary. This celebration isn't just about nostalgia—it's about making a splash in both the gaming and mobile app markets, and...

Continue Reading
NYSE Gains Ground with Historic Listings Transfers

Updated Category News Views 50

You'll know it's a topsy-turvy market when hefty firms start switching their stock exchange allegiance. This year, nine noteworthy companies, with a collective market heft of nearly half a trillion dollars, kissed Nasdaq goodbye and nestled into the New York Stock Exchange (NYSE). Now, why would these big shots make the shift, you ask? Let's dive into the nitty-gritty....

Continue Reading
Portillo's Faces Class Action Over Rapid Expansion

Updated Category News Views 0

Trouble Brews Over at Portillo's Inc. Here's a classic case of biting off more than one can chew. Portillo's Inc., known for its Chicago-style eats, is now facing the music for what seems to be an overly ambitious strategy. The San Diego-based law firm Robbins LLP has filed a class action lawsuit on behalf of all who've invested in this restaurant chain's stock between...

Continue Reading
UN Urges Real Progress on Climate at COP31 Summit

Updated Category News Views 36

When it comes to global climate action, meetings like the COP31 summit aren’t just another day in the office. Today, in Antalya, Türkiye, the talk was big, but the stakes are even bigger as business and UN leaders grappled with the nagging gap between corporate commitments and actual emissions reductions. The Urgency of 1.5°C Folks, we're skating on thin ice here with...

Continue Reading

Top 5 Most Recently Viewed Articles

Fuji Soft's Decision Amidst Competing Offers Explained

Updated Category News Views 115

Fuji Soft Inc. found itself in the thick of a bidding war back in 2024, grappling with two major offers for its shares. The board decided to endorse KKR & Co.'s tender offer even after Bain Capital stepped in with a juicier bid of ¥9,450 (around $63) per share, leaving many traders scratching their heads. Board's Backing: A Risky Gamble? The board's pledge to recommend...

Continue Reading
Miss Peaches and Spirit of Gallo Join Forces for a Cause

Updated Category News Views 677

Miss Peaches Collaborates with Spirit of Gallo The well-known 'furfluencer' Miss Peaches has partnered with Spirit of Gallo to introduce a unique product: Lucky One Lemonade. This innovative hard lemonade is crafted from premium vodka and boasts a non-carbonated formula, making it a standout option in the hard lemonade category. This initiative focuses on both delivering...

Continue Reading
GSI Technology's Innovative Edge Strategy in Drone Sector Growth

Updated Category News Views 148

Defining the Next Frontier: GSI Technology and Drone Market Growth GSI Technology, Inc. (Nasdaq: GSIT), renowned for its pioneering work with Associative Processing Units (APUs), is on a path to significantly transform the landscape of high-performance compute (HPC) processing. With its recent strategy to penetrate the booming drone market, GSI Technology aims to harness...

Continue Reading
Biohaven's BHV-1300: A Game Changer for Graves' Disease

Updated Category News Views 21

Biohaven's Bold Leap with BHV-1300 Sometimes in the biotech game, you meet a rookie that’s got the goods to shake up the entire league. Enter Biohaven Ltd.’s BHV-1300. It’s not just another player—it’s the first MoDE™ extracellular protein degrader swinging for autoimmune fences. This kid’s got something new up its sleeve, targeting those pesky antibodies...

Continue Reading
Polaris Slingshot Marks 10 Years with Stunning Limited Edition

Updated Category News Views 172

Polaris Slingshot Celebrates a Decade of Driving Innovation For ten incredible years, the Polaris Slingshot has been a sensation, captivating enthusiasts with its audacious design and exhilarating ride. Launched as a revolutionary three-wheeled motorcycle, the Slingshot quickly garnered a devoted fan base across North America and beyond. This year, Polaris is thrilled to...

Continue Reading